Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
Saved in:
| Title: | Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial. |
|---|---|
| Authors: | Johnston S; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Puhalla S; 2 Univeristy of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA., Wheatley D; 3 Royal Cornwall Hospitals National Health Service Foundation Trust, Treliske, United Kingdom., Ring A; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Barry P; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Holcombe C; 4 Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool, United Kingdom., Boileau JF; 5 Montreal Jewish General Hospital Segal Cancer Centre, Montreal, Quebec, Canada., Provencher L; 6 Centre Hospitalier Université de Quebec-Universite Laval, Quebec City, Quebec, Canada., Robidoux A; 7 Centre Hospitalier Université de Montréal, Montreal, Quebec, Canada., Rimawi M; 8 Baylor College of Medicine, Houston, TX., McIntosh SA; 9 Queen's University Belfast, Belfast, United Kingdom., Shalaby I; 10 Joe Arrington Cancer Research and Treatment Center, Lubbock, TX., Stein RC; 11 National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom.; 12 University College London Hospitals National Health Service Foundation Trust, London, United Kingdom., Thirlwell M; 13 McGill University Health Centre, Montreal, Quebec, Canada., Dolling D; 14 The Institute of Cancer Research, London, United Kingdom., Morden J; 14 The Institute of Cancer Research, London, United Kingdom., Snowdon C; 14 The Institute of Cancer Research, London, United Kingdom., Perry S; 14 The Institute of Cancer Research, London, United Kingdom., Cornman C; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA., Batten LM; 14 The Institute of Cancer Research, London, United Kingdom., Jeffs LK; 14 The Institute of Cancer Research, London, United Kingdom., Dodson A; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.; 14 The Institute of Cancer Research, London, United Kingdom., Martins V; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Modi A; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Osborne CK; 8 Baylor College of Medicine, Houston, TX., Pogue-Geile KL; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA., Cheang MCU; 14 The Institute of Cancer Research, London, United Kingdom., Wolmark N; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA., Julian TB; 16 Allegheny Health Network Cancer Institute, Pittsburgh, PA., Fisher K; 17 International Drug Development Institute, Brussels, Belgium., MacKenzie M; 18 Independent Cancer Patients Voice, London, United Kingdom., Wilcox M; 18 Independent Cancer Patients Voice, London, United Kingdom., Huang Bartlett C; 19 Pfizer, New York, NY., Koehler M; 20 Bicycle Therapeutics, Boston, MA., Dowsett M; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.; 14 The Institute of Cancer Research, London, United Kingdom., Bliss JM; 14 The Institute of Cancer Research, London, United Kingdom., Jacobs SA; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Jan 20; Vol. 37 (3), pp. 178-189. Date of Electronic Publication: 2018 Dec 06. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30523750 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Johnston+S%22">Johnston S</searchLink>; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Puhalla+S%22">Puhalla S</searchLink>; 2 Univeristy of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Wheatley+D%22">Wheatley D</searchLink>; 3 Royal Cornwall Hospitals National Health Service Foundation Trust, Treliske, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ring+A%22">Ring A</searchLink>; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barry+P%22">Barry P</searchLink>; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Holcombe+C%22">Holcombe C</searchLink>; 4 Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Boileau+JF%22">Boileau JF</searchLink>; 5 Montreal Jewish General Hospital Segal Cancer Centre, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Provencher+L%22">Provencher L</searchLink>; 6 Centre Hospitalier Université de Quebec-Universite Laval, Quebec City, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Robidoux+A%22">Robidoux A</searchLink>; 7 Centre Hospitalier Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Rimawi+M%22">Rimawi M</searchLink>; 8 Baylor College of Medicine, Houston, TX.<br /><searchLink fieldCode="AU" term="%22McIntosh+SA%22">McIntosh SA</searchLink>; 9 Queen's University Belfast, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Shalaby+I%22">Shalaby I</searchLink>; 10 Joe Arrington Cancer Research and Treatment Center, Lubbock, TX.<br /><searchLink fieldCode="AU" term="%22Stein+RC%22">Stein RC</searchLink>; 11 National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom.; 12 University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thirlwell+M%22">Thirlwell M</searchLink>; 13 McGill University Health Centre, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Dolling+D%22">Dolling D</searchLink>; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Morden+J%22">Morden J</searchLink>; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Snowdon+C%22">Snowdon C</searchLink>; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Perry+S%22">Perry S</searchLink>; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cornman+C%22">Cornman C</searchLink>; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Batten+LM%22">Batten LM</searchLink>; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jeffs+LK%22">Jeffs LK</searchLink>; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dodson+A%22">Dodson A</searchLink>; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Martins+V%22">Martins V</searchLink>; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Modi+A%22">Modi A</searchLink>; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Osborne+CK%22">Osborne CK</searchLink>; 8 Baylor College of Medicine, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Pogue-Geile+KL%22">Pogue-Geile KL</searchLink>; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Cheang+MCU%22">Cheang MCU</searchLink>; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wolmark+N%22">Wolmark N</searchLink>; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Julian+TB%22">Julian TB</searchLink>; 16 Allegheny Health Network Cancer Institute, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Fisher+K%22">Fisher K</searchLink>; 17 International Drug Development Institute, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22MacKenzie+M%22">MacKenzie M</searchLink>; 18 Independent Cancer Patients Voice, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wilcox+M%22">Wilcox M</searchLink>; 18 Independent Cancer Patients Voice, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Huang+Bartlett+C%22">Huang Bartlett C</searchLink>; 19 Pfizer, New York, NY.<br /><searchLink fieldCode="AU" term="%22Koehler+M%22">Koehler M</searchLink>; 20 Bicycle Therapeutics, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Dowsett+M%22">Dowsett M</searchLink>; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bliss+JM%22">Bliss JM</searchLink>; 14 The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jacobs+SA%22">Jacobs SA</searchLink>; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2019 Jan 20; Vol. 37 (3), pp. 178-189. <i>Date of Electronic Publication: </i>2018 Dec 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30523750 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/JCO.18.01624 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 178 Titles: – TitleFull: Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Johnston S – PersonEntity: Name: NameFull: Puhalla S – PersonEntity: Name: NameFull: Wheatley D – PersonEntity: Name: NameFull: Ring A – PersonEntity: Name: NameFull: Barry P – PersonEntity: Name: NameFull: Holcombe C – PersonEntity: Name: NameFull: Boileau JF – PersonEntity: Name: NameFull: Provencher L – PersonEntity: Name: NameFull: Robidoux A – PersonEntity: Name: NameFull: Rimawi M – PersonEntity: Name: NameFull: McIntosh SA – PersonEntity: Name: NameFull: Shalaby I – PersonEntity: Name: NameFull: Stein RC – PersonEntity: Name: NameFull: Thirlwell M – PersonEntity: Name: NameFull: Dolling D – PersonEntity: Name: NameFull: Morden J – PersonEntity: Name: NameFull: Snowdon C – PersonEntity: Name: NameFull: Perry S – PersonEntity: Name: NameFull: Cornman C – PersonEntity: Name: NameFull: Batten LM – PersonEntity: Name: NameFull: Jeffs LK – PersonEntity: Name: NameFull: Dodson A – PersonEntity: Name: NameFull: Martins V – PersonEntity: Name: NameFull: Modi A – PersonEntity: Name: NameFull: Osborne CK – PersonEntity: Name: NameFull: Pogue-Geile KL – PersonEntity: Name: NameFull: Cheang MCU – PersonEntity: Name: NameFull: Wolmark N – PersonEntity: Name: NameFull: Julian TB – PersonEntity: Name: NameFull: Fisher K – PersonEntity: Name: NameFull: MacKenzie M – PersonEntity: Name: NameFull: Wilcox M – PersonEntity: Name: NameFull: Huang Bartlett C – PersonEntity: Name: NameFull: Koehler M – PersonEntity: Name: NameFull: Dowsett M – PersonEntity: Name: NameFull: Bliss JM – PersonEntity: Name: NameFull: Jacobs SA IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 01 Text: 2019 Jan 20 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1527-7755 Numbering: – Type: volume Value: 37 – Type: issue Value: 3 Titles: – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Type: main |
| ResultId | 1 |